Neurology
Migraine Still Refuses a Simple Blood Test
A large Danish registry study challenges the idea that plasma CGRP can serve as a diagnostic biomarker for migraine. The pathway matters. The blood test may not.
Alzheimer’s Trials Still Measure Too Little, Too Late
Eight Patients Cannot Solve Alzheimer’s. They Can Tell Us What the Next Trial Must Prove.
The ICU Has a New Signal. It Is Not a Verdict.
The Trial Has Started. Now the System Has to Find the Children.
Sleep is now cardiovascular prevention. Health systems still treat it like lifestyle advice
ADHD Does Not Stop Being ADHD When Anxiety Walks Into the Room
Dementia prevention has a cardiometabolic blind spot
Huntington’s Needs More Than a Better Curve
Duchenne’s Accelerated Approval Faces Its Test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.